These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22750632)

  • 21. The effects of increased central serotonergic activity on prepulse inhibition and habituation of the human startle response.
    Jensen KS; Oranje B; Wienberg M; Glenthøj BY
    Neuropsychopharmacology; 2007 Oct; 32(10):2117-24. PubMed ID: 17299503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonidine augmentation in patients with schizophrenia: A double-blind, randomized placebo-controlled trial.
    Kruiper C; Sommer IEC; Koster M; Bakker PR; Durston S; Oranje B
    Schizophr Res; 2023 May; 255():148-154. PubMed ID: 36989672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.
    Kucinski A; Syposs C; Wersinger S; Bencherif M; Stachowiak MK; Stachowiak EK
    Schizophr Res; 2012 Apr; 136(1-3):82-7. PubMed ID: 22285656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder.
    Cadenhead KS; Geyer MA; Braff DL
    Am J Psychiatry; 1993 Dec; 150(12):1862-7. PubMed ID: 8238643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission.
    Perry W; Feifel D; Minassian A; Bhattacharjie I; Braff DL
    Am J Psychiatry; 2002 Aug; 159(8):1375-81. PubMed ID: 12153831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR; Light GA; Cadenhead KS; Sprock J; Hsieh MH; Braff DL
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prepulse inhibition of the startle response with chronic schizophrenia: a replication study.
    Moriwaki M; Kishi T; Takahashi H; Hashimoto R; Kawashima K; Okochi T; Kitajima T; Furukawa O; Fujita K; Takeda M; Iwata N
    Neurosci Res; 2009 Nov; 65(3):259-62. PubMed ID: 19660506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A large single ethnicity study of prepulse inhibition in schizophrenia: Separate analysis by sex focusing on effect of symptoms.
    Matsuo J; Ota M; Hori H; Hidese S; Teraishi T; Ishida I; Hiraishi M; Kunugi H
    J Psychiatr Res; 2016 Nov; 82():155-62. PubMed ID: 27505440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of memantine on prepulse inhibition.
    Swerdlow NR; van Bergeijk DP; Bergsma F; Weber E; Talledo J
    Neuropsychopharmacology; 2009 Jun; 34(7):1854-64. PubMed ID: 19242406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired prepulse inhibition of acoustic startle in schizophrenia.
    Parwani A; Duncan EJ; Bartlett E; Madonick SH; Efferen TR; Rajan R; Sanfilipo M; Chappell PB; Chakravorty S; Gonzenbach S; Ko GN; Rotrosen JP
    Biol Psychiatry; 2000 Apr; 47(7):662-9. PubMed ID: 10745060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients.
    Csomor PA; Yee BK; Feldon J; Theodoridou A; Studerus E; Vollenweider FX
    Schizophr Bull; 2009 Jan; 35(1):244-55. PubMed ID: 18245063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the role of alpha-2 adrenergic receptors on prepulse inhibition of acoustic startle reflex in rats.
    Ozcetin A; Cevreli B; Uzbay T
    Synapse; 2016 Dec; 70(12):501-507. PubMed ID: 27399264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol.
    Oranje B; Kahn RS; Kemner C; Verbaten MN
    Psychiatry Res; 2004 Jul; 127(3):195-205. PubMed ID: 15296819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prepulse inhibition of the startle reflex in schizophrenia remains stable with short-term quetiapine.
    Molina V; López DE; Villa R; Pérez J; Martín C; Ballesteros A; Cardoso A; Sancho C
    Eur Psychiatry; 2011; 26(5):271-5. PubMed ID: 20542668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired sensorimotor gating in patients with non-epileptic seizures.
    Pouretemad HR; Thompson PJ; Fenwick PB
    Epilepsy Res; 1998 Jun; 31(1):1-12. PubMed ID: 9696296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.
    Hasenkamp W; Epstein MP; Green A; Wilcox L; Boshoven W; Lewison B; Duncan E
    Psychiatry Res; 2010 Jul; 178(2):236-43. PubMed ID: 20483176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gating and habituation of the startle reflex in schizophrenic patients.
    Braff DL; Grillon C; Geyer MA
    Arch Gen Psychiatry; 1992 Mar; 49(3):206-15. PubMed ID: 1567275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low dose ketamine increases prepulse inhibition in healthy men.
    Abel KM; Allin MP; Hemsley DR; Geyer MA
    Neuropharmacology; 2003 May; 44(6):729-37. PubMed ID: 12681371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients.
    Swerdlow NR; Bhakta SG; Talledo JA; Franz DM; Hughes EL; Rana BK; Light GA
    Neuropsychopharmacology; 2018 Mar; 43(4):708-717. PubMed ID: 29154367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.